Market Tracker

08/27 6:05pm ET

Synageva BioPharma Corp (NASDAQ:GEVA)

During the Trading Day
77.07 +0.10 / +0.13%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
76.71 -0.3635 / -0.47%
 
Volume: 3.8K
No recent news for Synageva BioPharma Corp.

Today’s Trading

Previous close76.97
Today’s open77.36
Day’s range76.23 - 79.33
Volume197,630
Average volume (3 months)275,726
Market cap$2.6B
Dividend yield--
Data as of 3:59pm ET, 08/27/2014

Growth & Valuation

Earnings growth (last year)-78.95%
Earnings growth (this year)-81.03%
Earnings growth (next 5 years)+36.00%
Revenue growth (last year)-10.57%
P/E ratioNM
Price/Sales135.92
Price/Book5.50

Competitors

 Today’s
change
Today’s
% change
XONIntrexon Corp+0.05+0.24%
OPHTOphthotech Corp-0.40-1.00%
HALOHalozyme Therapeutic...-0.15-1.52%
NVAXNovavax Inc-0.06-1.25%
Data as of 4:02pm ET, 08/27/2014

Financials

Next reporting dateNovember 4, 2014
EPS forecast (this quarter)-$1.65
Annual revenue (last year)$13.4M
Annual profit (last year)-$95.5M
Net profit margin-713.70%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Sanj K. Patel
Chief Financial Officer &
Senior Vice President
Carsten Boess
Corporate headquarters
Lexington, Massachusetts

Forecasts